← Back to Search

Metformin therapy for Prediabetes

N/A
Waitlist Available
Led By Andrea Cherrington, MD, MPH
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is designed to test a new way to prevent diabetes that could help people in rural counties of Alabama and in the Mississippi delta who are especially vulnerable to the disease.

Eligible Conditions
  • Prediabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Body Weight
Change in Glycosylated Hemoglobin (HbA1c)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Receive lifestyle modification with metformin therapyExperimental Treatment2 Interventions
Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services plus metformin recommendation
Group II: Receive lifestyle modification alone (DPP)Active Control1 Intervention
Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Metformin therapy
2020
N/A
~40
Receive lifestyle modification alone
2020
N/A
~40

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,376 Previous Clinical Trials
4,315,731 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,594 Previous Clinical Trials
2,283,059 Total Patients Enrolled
Andrea Cherrington, MD, MPHPrincipal Investigator - University of Alabama at Birmingham
University of Alabama at Birmingham

Media Library

Lifestyle Modification Clinical Trial Eligibility Overview. Trial Name: NCT04343872 — N/A
Prediabetes Research Study Groups: Receive lifestyle modification alone (DPP), Receive lifestyle modification with metformin therapy
Prediabetes Clinical Trial 2023: Lifestyle Modification Highlights & Side Effects. Trial Name: NCT04343872 — N/A
Lifestyle Modification 2023 Treatment Timeline for Medical Study. Trial Name: NCT04343872 — N/A
~8 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top